297 related articles for article (PubMed ID: 31179339)
1. Effect of Baoshenfang Formula on Podocyte Injury via Inhibiting the NOX-4/ROS/p38 Pathway in Diabetic Nephropathy.
Cui FQ; Tang L; Gao YB; Wang YF; Meng Y; Shen C; Shen ZL; Liu ZQ; Zhao WJ; Liu WJ
J Diabetes Res; 2019; 2019():2981705. PubMed ID: 31179339
[TBL] [Abstract][Full Text] [Related]
2. Effects of BSF on Podocyte Apoptosis via Regulating the ROS-Mediated PI3K/AKT Pathway in DN.
Cui FQ; Wang YF; Gao YB; Meng Y; Cai Z; Shen C; Liu ZQ; Jiang XC; Zhao WJ
J Diabetes Res; 2019; 2019():9512406. PubMed ID: 31886291
[TBL] [Abstract][Full Text] [Related]
3. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
[TBL] [Abstract][Full Text] [Related]
4. miR-423-5p suppresses high-glucose-induced podocyte injury by targeting Nox4.
Xu Y; Zhang J; Fan L; He X
Biochem Biophys Res Commun; 2018 Oct; 505(2):339-345. PubMed ID: 30245133
[TBL] [Abstract][Full Text] [Related]
5. Hirudin Protects Against Kidney Damage in Streptozotocin-Induced Diabetic Nephropathy Rats by Inhibiting Inflammation via P38 MAPK/NF-κB Pathway.
Han J; Pang X; Zhang Y; Peng Z; Shi X; Xing Y
Drug Des Devel Ther; 2020; 14():3223-3234. PubMed ID: 32848363
[TBL] [Abstract][Full Text] [Related]
6. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.
Toyonaga J; Tsuruya K; Ikeda H; Noguchi H; Yotsueda H; Fujisaki K; Hirakawa M; Taniguchi M; Masutani K; Iida M
Nephrol Dial Transplant; 2011 Aug; 26(8):2475-84. PubMed ID: 21220752
[TBL] [Abstract][Full Text] [Related]
7. The protective effect and mechanism of catalpol on high glucose-induced podocyte injury.
Chen Y; Liu Q; Shan Z; Zhao Y; Li M; Wang B; Zheng X; Feng W
BMC Complement Altern Med; 2019 Sep; 19(1):244. PubMed ID: 31488111
[TBL] [Abstract][Full Text] [Related]
8. Loganin and catalpol exert cooperative ameliorating effects on podocyte apoptosis upon diabetic nephropathy by targeting AGEs-RAGE signaling.
Chen Y; Chen J; Jiang M; Fu Y; Zhu Y; Jiao N; Liu L; Du Q; Wu H; Xu H; Sun J
Life Sci; 2020 Jul; 252():117653. PubMed ID: 32277978
[TBL] [Abstract][Full Text] [Related]
9. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
10. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
11. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
12. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
[TBL] [Abstract][Full Text] [Related]
13. Effect of Tang-Shen-Ning decoction on podocyte epithelial-esenchymal transformation via inhibiting Wnt/β-catenin pathway in diabetic mice.
Cui FQ; Gao YB; Wang YF; Meng Y; Cai Z; Shen C; Jiang XC; Zhao WJ
Ann Palliat Med; 2021 Dec; 10(12):12921-12936. PubMed ID: 32921066
[TBL] [Abstract][Full Text] [Related]
14. Naringin ameliorates diabetic nephropathy by inhibiting NADPH oxidase 4.
Zhang J; Yang S; Li H; Chen F; Shi J
Eur J Pharmacol; 2017 Jun; 804():1-6. PubMed ID: 28395989
[TBL] [Abstract][Full Text] [Related]
15. Nicotine Induces Podocyte Apoptosis through Increasing Oxidative Stress.
Lan X; Lederman R; Eng JM; Shoshtari SS; Saleem MA; Malhotra A; Singhal PC
PLoS One; 2016; 11(12):e0167071. PubMed ID: 27907022
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy.
Wang F; Li R; Zhao L; Ma S; Qin G
Eur J Pharmacol; 2020 Oct; 885():173387. PubMed ID: 32710953
[TBL] [Abstract][Full Text] [Related]
18. Tongluo Digui decoction treats renal injury in diabetic rats by promoting autophagy of podocytes.
Han J; Zhang Y; Shi X; Peng Z; Xing Y; Pang X
J Tradit Chin Med; 2021 Feb; 41(1):125-132. PubMed ID: 33522205
[TBL] [Abstract][Full Text] [Related]
19. High glucose provokes microvesicles generation from glomerular podocytes via NOX4/ROS pathway.
Li M; Zhang T; Wu X; Chen Y; Sun L
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31664454
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway.
He T; Xiong J; Nie L; Yu Y; Guan X; Xu X; Xiao T; Yang K; Liu L; Zhang D; Huang Y; Zhang J; Wang J; Sharma K; Zhao J
J Mol Med (Berl); 2016 Dec; 94(12):1359-1371. PubMed ID: 27488452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
